Caribou Biosciences Job Trends

Caribou Biosciences logo
1
Active Jobs (Last 14 Days)
0
Fresh Jobs (Last 3 Days)
100%
Jobs with Salary Data

Recent Job Posting Activity (30 Days)

Caribou Biosciences 30-day hiring trend

Job Category Distribution

Caribou Biosciences job category distribution
Data spans Nov 13, 2025 through Dec 13, 2025, aggregated by PharmaPayWatch.com. Recent job postings shows the number of jobs posted each day (bars) for the past 30 days with an overlay of the 7 day running average. The rose plot shows how PharmaPayWatch categorizes those jobs to get a better sense of Caribou Biosciences's recent hiring focus. Note that some jobs aren't categorized by our filters, we exclude those from the rose plot.

Current Caribou Biosciences Jobs, Salary Data, and Stats

In the last two weeks, Caribou Biosciences has posted 1 positions. 100% of those roles offer remote or hybrid work. We've been tracking Caribou Biosciences since April 27, 2025.

Career Tracks Currently Hiring

Quality & Regulatory Clinical Operations Software & IT Other Medical Practice

Currently Hiring Office Locations

Berkeley, California, United States Hybrid, Berkeley, California, United States Hybrid, Berkeley, California, United States, Remote Berkeley, CA (Hybrid)

Current Caribou Biosciences Jobs

Last updated: Dec 13, 2025

Showing 1 active jobs. Active jobs were posted in the last 14 days. Fresh jobs were posted within the last 3 days. Click a row for more details.

Role

Director of Quality Assurance, Clinical

Remote Quality Dec 1
$220,000 - $235,000
Hybrid, Berkeley, California, United States, Remote
Apply →
Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology enables superior precision to develop cell therapies that are armored to potentially improve activity against diseases. We believe the future of cell therapy is off-the-shelf, and we are advancing our pipeline of off-the-shelf, or allogeneic, cell therapies from our CAR-T cell therapy platform as readily available treatments for patients with hematologic malignancies and autoimmune diseases. Members of the Caribou herd open their minds to new ideas and welcome diverse perspectives. We proudly assert that teams do...